1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Murphy Canyon Acquisition Corp.

Murphy Canyon Acquisition Corp.

MURF
Murphy Canyon Acquisition Corp.US flagNASDAQ Global Market
16.85
USD
-0.14
- -
105.28MMarket Cap
Murphy Canyon Acquisition Corp.
MURF
(NASDAQ Global Market)

Recent

price

16.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
10X Capital Venture Acquisition Corp (VCVCU)
SILVERspac Inc. (SLVRU)
ROC Energy Acquisition Corp. (ROCAR)
FAST Acquisition Corp. II (FZT-WT)
Noble Rock Acquisition Corporation (NRACU)
Stellar V Capital Corp. Class A Ordinary Shares (SVCC)
Business
Murphy Canyon Acquisition Corp. previously operated as a special purpose acquisition company, without substantial active operations. Its principal mission involved executing a merger, share exchange, asset acquisition, or similar business combination with an existing enterprise. Although it initially targeted the real estate industry, including construction, property management, financing arrangements, and associated technologies, the company ultimately completed a business combination with Conduit Pharmaceuticals Limited. This transaction finalized in September 2023. The resulting combined entity now operates as Conduit Pharmaceuticals Inc., focusing on life sciences and the development of clinical drug candidates, with its shares trading on Nasdaq under new symbols. The blank check firm was established in 2021 and maintained its corporate base in San Diego, California.